Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubiprosterone as adjunct for bowel preparation in constipated patients undergoing colonoscopy
ChiCTR2400092647Phase 4Not yet recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Lubicosa in chronic constipation (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Intestinal preparation quality. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
Lubicosa
03
Conditions
chronic constipation
Beyond the preview
Go deeper on ChiCTR2400092647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092647.